Stock listing

Stockholm:XINT Xintela AB Aktie

Home listing (Stockholm) of Xintela AB

Follow Xintela AB into a list and get an email when it puts out news.

Share price · OMXSTO:XINT

0.156 SEK -0.002 (-1.0%)

Close on Oct 30, 2026

Past year -62.8% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
0.147 – 0.156 SEKOct 30, 2026
Volume
11,561 sharesOct 30, 2026
Market cap
134.4M SEKAt the close on Oct 30, 2026 · price × 861.3M shares outstanding
52-week range
0.142 – 0.479 SEKLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
39,026 SEKMedian day 149,150 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Xintela AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:XINT · Home0.156 SEK-0.002 (-1.0%)11,5610.1470.1560.1470.158Close on Oct 30, 2026
Frankfurt:1XT€0.0022 EUR-0.0006 (-21.4%)—€0.0022€0.0022€0.0022€0.0028Close on Oct 30, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXSTO:XINT · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.156-0.002-1.0%0.1470.1560.14711,561
0.158+0.004+2.6%0.1450.1590.145468,793
0.154-0.011-6.7%0.1700.1700.150463,883
0.165-0.001-0.6%0.1660.1740.152451,658
0.166-0.011-6.2%0.1750.1750.15175,114
0.177-0.001-0.3%0.1770.1800.162192,946
0.177+0.007+4.1%0.1790.1790.161129,817
0.170+0.006+3.7%0.1750.1800.17091,834
0.164+0.006+3.8%0.1580.1700.154372,083
0.158-0.003-1.9%0.1550.1580.151283,745
0.161-0.002-0.9%0.1620.1620.148113,885
0.163-0.001-0.6%0.1600.1670.154142,392
0.164-0.004-2.1%0.1510.1700.14215,080
0.167-0.008-4.8%0.1810.1810.144283,565
0.176-0.004-2.2%0.1650.1840.164146,896
0.180+0.020+12.9%0.1510.1800.151677,358
0.159+0.008+5.3%0.1660.1660.150423,458
0.151-0.009-5.6%0.1600.1600.151209,429
0.160-0.010-5.6%0.1630.1670.150272,796
0.170-0.005-2.9%0.1750.1750.16345,608
0.175-0.005-2.8%0.1800.1800.17059,620
0.180+0.003+1.4%0.1770.1800.17715,550
0.177+0.004+2.0%0.1770.1770.17052,268
0.174+0.012+7.4%0.1730.1770.171147,067
0.162-0.001-0.3%0.1760.1760.162146,055
0.162-0.010-5.8%0.1720.1720.161126,971
0.172+0.001+0.6%0.1710.1770.153123,594
0.171+0.004+2.4%0.1670.1770.16610,655
0.167+0.010+6.0%0.1530.1670.153279,426
0.158-0.004-2.2%0.1530.1600.15356,350
0.1610.0000.0%0.1610.1610.1615,920
0.1610.0000.0%0.1520.1610.15211,470
0.161+0.003+1.9%0.1580.1610.15865,886
0.158-0.002-1.3%0.1580.1590.15550,150
0.160-0.005-3.0%0.1540.1610.151179,844
0.165+0.006+3.8%0.1650.1650.165500
0.159-0.003-1.5%0.1620.1700.15993,045
0.162+0.005+2.9%0.1570.1650.157207,179
0.157-0.003-1.6%0.1600.1600.15499,383
0.160+0.003+1.6%0.1570.1600.153249,416
0.157-0.003-1.9%0.1610.1610.150520,563
0.160-0.008-4.8%0.1680.1680.160239,714
0.168+0.003+1.8%0.1650.1690.16357,790
0.1650.0000.0%0.1650.1650.160284,733
0.165-0.005-2.7%0.1650.1670.156388,363
0.170-0.008-4.8%0.1870.2100.1541,188,981
0.178-0.004-1.9%0.1760.1880.174376,103
0.182-0.001-0.3%0.1880.1880.174472,254
0.182+0.005+2.8%0.1770.1820.169486,832
0.177-0.009-4.8%0.1860.1870.173548,624
0.186+0.001+0.5%0.1830.1870.180159,356
0.185-0.006-3.1%0.1810.1990.180502,801
0.191-0.003-1.5%0.1950.1950.180353,534
0.194+0.002+1.0%0.1940.1940.18318,041
0.192+0.006+3.2%0.1920.1920.178189,922
0.186+0.001+0.3%0.1870.1920.178112,494
0.186+0.005+2.5%0.1810.1950.175530,440
0.181-0.004-2.2%0.1850.1850.175145,432
0.185+0.004+1.9%0.1760.1880.176357,528
0.182-0.005-2.7%0.1780.1820.171259,328
0.187+0.001+0.3%0.1780.1890.177125,186
0.186-0.003-1.3%0.1890.1890.175251,383
0.189-0.002-1.0%0.1890.1890.17768,545
0.191+0.010+5.2%0.1790.1930.176371,966
0.181-0.008-4.2%0.2000.2000.180149,150
0.189+0.001+0.3%0.2000.2000.18395,570
0.189-0.010-5.0%0.1980.1980.184108,158
Ticker
Stockholm:XINT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stockholm
Currency
SEK

What changed lately

Latest news

Interim Report January – June 2026

Aug 28, 2026

Closed 0.17 (-4.8%) on Aug 28, 2026

Xintela AB Interim Report January - June 2026

Aug 28, 2026

Closed 0.17 (-4.8%) on Aug 28, 2026

Xintela publishes safety and efficacy results from knee osteoarthritis clinical study with XSTEM in scientific journal

Aug 11, 2026

Closed 0.185 (+1.9%) on Aug 11, 2026

Xintela AB Interim Report January - March 2026

May 29, 2026

Closed 0.228 (-5.4%) on May 29, 2026

Xintela AB changes Certified Adviser to Västra Hamnen Corporate Finance AB

May 28, 2026

Closed 0.241 (-3.6%) on May 28, 2026

Xintela granted patent in Japan for XSTEM® treatment of acute respiratory distress syndrome (ARDS)

May 12, 2026

Closed 0.259 (-5.5%) on May 12, 2026

Xintela AB publishes Annual Report 2025

Apr 30, 2026

Closed 0.234 (-1.7%) on Apr 30, 2026

Xintela granted US patent for XSTEM treatment of difficult-to-heal wounds and skin defects

Apr 14, 2026

Closed 0.30 (+3.8%) on Apr 14, 2026

Xintela AB Year-end Report 2025

Feb 27, 2026

Closed 0.277 (+1.8%) on Feb 27, 2026

Xintela completes clinical study with XSTEM in difficult-to-heal leg ulcers

Feb 13, 2026

Closed 0.279 (-3.5%) on Feb 13, 2026

All Xintela AB news

Xintela AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 15 in all · newest Aug 28, 2026 · oldest 2025

Where Xintela AB is listed

ListingExchangeCountryCurrency
Stockholm:XINT · Home listing · This pageStockholmSwedenSEK
Frankfurt:1XTFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Xintela AB.